Good Morning, The Scott Partnership?

Hello! My name is Rebecca and I am excited to say that I am the new addition to The Scott Partnership PR agency team.

Before joining The Scott Partnership I was a French and Spanish student at Lancaster University. Within four days of getting my results I had transformed from a nocturnal fancy dress connoisseuse (see, my French still comes in handy) to a 9-5 professional. I can’t say that I don’t miss hour-long Facebook stalking sessions and knowing 6am as bedtime rather than wake-up time but my first two weeks have been absolutely brilliant.

If someone had stopped me prior to this fortnight and asked what coverage was, what function a press release serves, or even what the position “Account Executive” entailed I would have just looked back at them blankly. Thanks to everyone at TSP being so friendly, welcoming and eager to help I would now be able to confidently answer each of those questions (and maybe even a few more!).

I won’t try and pretend that I am not still petrified of the phone, don’t ask about a million questions per hour and don’t have mild palpitations when I hear the sentence “write a PR on mass spectrometry”. However, the induction gave me a thorough understanding of day-to-day PR life. Emailing editors, clipping coverage, writing PRs, liaising with clients, amending articles are all a huge part of my week.  I have been introduced to a few of the client accounts in the pharmaceutical and drug discovery sectors that I will be working on and have been shown the vast network that requires sat-nav to navigate successfully at first. As a result I am really starting to get a feel for what we are all about: professionalism and dedication to service.

So far, so good. With the company’s ambitious strategy and recent new client wins it is a really exciting time to have started at TSP and besides, I really love that little impressed look that people do when I tell them I work in PR.

One of the most important things I have learnt since being at TSP? Always remember dress-down Friday, or you spend the whole day feeling like the one child that came to school in shirt, tie and blazer on non-uniform day.

The Scott Partnership Launches Corporate Communications Practice In Line with Growth Strategy

Cheshire, UK (July, 2011) - The Scott Partnership, a leading global business-to-business PR and marketing communications consultancy based in Cheshire, UK, announces the launch of a Corporate Communications practice.

The launch of the Corporate Communications practice comes on the back of fifteen consecutive years of growth, which has seen The Scott Partnership outperform the industry. It comes one year after the successful opening of offices in both North America and China.

Thermo Fisher Scientific Launches New LIMS for Clinical Laboratories at AACC 2011

Thermo Scientific Clinical LIMS Delivers a Lab-Centric Solution for Patient-Centric Results

ATLANTA (July 27, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new informatics solution to support clinical laboratories serving the emerging fields of translational and personalized medicine. Thermo Scientific Clinical LIMS (laboratory information management system) is a fully functional data and sample management system that is designed to improve the management of laboratory workflow and drive a clinical lab’s processes while enabling bi-directional communication between physicians and the lab. Thermo Scientific Clinical LIMS delivers the end-to-end laboratory data and patient data management functionality needed by scientists and technicians involved in clinical and molecular diagnostics and related research. The new Clinical LIMS is an important addition to the Thermo Fisher Scientific portfolio of products that support laboratories in their efforts to deliver advanced testing capabilities to hospitals and clinicians, and enables an end-to-end solution that supports labs from sample preparation to final patient results. The company will showcase the products at Thermo Scientific booth #1720 during Clinical Lab Expo at AACC 2011, being held July 26 – July 28, at the Georgia World Congress Center, Atlanta, Georgia.

Thermo Fisher Scientific Introduces Workflows at AACC 2011 to Accelerate Results in the Clinical Laboratory

Innovation Improves Laboratory Productivity Across Sample Handling, Analysis, Storage and Protection

ATLANTA (July 26, 2011) - Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a comprehensive range of clinical research and diagnostic products at the annual conference of the American Association for Clinical Chemistry (AACC). From automated sample handling to innovative sample analysis and storage solutions, ThermoFisher provides an integrated approach to accelerating results in the clinical laboratory. Visit Booth #1720 during Clinical Lab Expo at the AACC conference being held at the Georgia World Congress Center, Atlanta, Georgia, from July 26-28.

Novozymes Biopharma secures business innovation award

Company recognized for its commitment to pushing back scientific frontiers and developing solutions that enhance the manufacture of medical devices and pharmaceuticals

NOTTINGHAM, UK – July 21, 2011 – Novozymes Biopharma, part of Novozymes A/S, world leader in bioinnovation, received the 2011 Nottingham Evening Post
(NEP) Business Award in the business innovation category, for its innovative recombinant human albumin range. The company has been recognized for its outstanding contribution to pushing back scientific frontiers by developing innovative, process improving solutions for the medical device and pharmaceutical manufacturing industries. The NEP business awards are designed to reward organizations in the region for setting new benchmarks in their industries and the company is delighted to add this accolade to its growing collection of awards.

Thermo Fisher Scientific Presents $35,000 Distinguished Research Award to Dr. Judit Villen, University of Washington

Innovative Research Begins New Era of Mass Spectrometry-Based Single-Cell Measurements to Enhance Understanding of the Growth, Proliferation and Differentiation of Cells.

SAN JOSE, Calif. (July 21, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has presented Dr. Judit Villen of the University of Washington, Seattle, with the renowned American Society for Mass Spectrometry (ASMS) 2011 Research Award of $35,000. Sponsored by Thermo Fisher Scientific for more than 20 years and administered by ASMS, the annual award recognizes and supports breakthrough academic research by young scientists in the field of mass spectrometry (MS). The award has propelled many past recipients to leadership positions in MS research. Dr. Villen received the award during a ceremony at the Wells Fargo Theatre in Denver during the 2011 ASMS conference.

Thermo Fisher Scientific Wins R&D 100 Award with UV-Vis Spectrophotometer

MADISON, Wisconsin (July 20, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Evolution 200 series of next-generation UV-Visible spectrophotometers featuring INSIGHT and CUE (Customized User Environment) software has been named one of the most technologically significant products of the past 12 months by R&D Magazine. Designed for analyses in the QA/QC, life science, and material science industries, the instruments combine high performance and straightforward software, enabling personalized operation for greater productivity.  The Thermo Scientific Evolution 200 series was recognized for the unique nature of the platform for spectroscopy analyses that can be tailored to individual measurements.

Next-generation INSIGHT software has been designed to improve the user experience by simplifying method creation and results interpretation. INSIGHT software also includes CUE scripting capabilities, which enables the user to create a dedicated analyzer with a simplified, customized user interface to streamline workflows, enforce proper procedures, and reduce errors. CUE scripts can be locked from further editing, resulting in custom programs that can be run in regulatory environments. This is an industry first.

Optibrium Launches New Version of Free StarVue App

Providing an Enhanced Solution for Viewing Compound Structures and Data in Drug Discovery

CAMBRIDGE, UK, July, 19, 2011 – Optibrium, a provider of software solutions for drug discovery, today launches a new version of StarVue, its innovative free desktop application that enables scientists to quickly and conveniently view sets of compound structures and related data. The latest version of StarVue can be downloaded free from Optibrium’s on-line community at www.optibrium.com/starvue/.

Llantrisant, UK (July 19, 2011): ALMSCO International, a division of Markes International Ltd., today announced a new high definition GC/MS method enabling scientists to screen for persistent organic pollutants (POPs) such as pesticides at trace levels in complex apple matrices, without dependence on extensive sample clean-up. The new method, which is one component of ALMSCO’s extensive food safety offering, is designed to offer optimal sensitivity without comprising speed of analyses and selectivity. This application is detailed in a poster entitled “Environmental and food safety screening of persistent organic pollutants (POPs) by GC(xGC)/TOF MS without dependence on extensive sample clean-up”, and is available via http://www.almsco.com/downloads/publications.aspx.

Persistent organic pollutants (POPs), including pesticides and dioxins, are chemical compounds produced by human activity and are widely distributed in the environment by natural processes, persisting for many years after forming. POPs become more concentrated as they move up the food chain and food is therefore the most common source of human exposure to these dangerous substances. Pesticides are often used to prevent, destroy and control pests on food crops and can leave residues on agricultural products. This poses a risk to consumers and consumption can result in effects ranging from short-term health problems such as headaches and dizziness to long-term damage to the nervous system and, in some cases, cancer.

ITT to acquire YSI Incorporated; deal strengthens company's water instrumentation business

WHITE PLAINS, N.Y., and YELLOW SPRINGS, OHIO, July 11, 2011 - ITT Corporation (NYSE: ITT) and privately held YSI Incorporated today announced that they have entered into a definitive agreement for ITT to acquire, via merger, YSI, a leading developer and manufacturer of sensors, instruments, software, and data collection platforms for environmental water monitoring.The financial terms of the proposal were not disclosed. YSI had 2010 global revenues of $101 million and employs 390 people at several facilities in the U.S., Europe and Asia. Completion of the acquisition is expected in the third quarter 2011, pending customary closing conditions and approval from YSI's shareholders.

"The addition of YSI is the next logical step in our strategy to acquire attractive companies whose businesses complement our existing water portfolio," said Gretchen McClain, president of ITT's Fluid and Motion Control business, and future chief executive officer of the new standalone water company that will separate from ITT later this year. "We see very compelling growth characteristics in the analytical instrumentation market.
As we move toward the formation of our new water company, the addition of YSI further builds on our attractive analytics business and our commitment to provide the best solutions to the challenges our customers face across the water industry."

Novozymes Biopharma to present latest advances in drug delivery technology at Controlled Release Society Meeting

NOTTINGHAM, UK – July 6, 2011 – Novozymes Biopharma, part of Novozymes A/S, world leader in bioinnovation, today announced two new scientific posters to be presented at the 2011 Controlled Release Society (CRS) meeting and exposition, July 30–August 3, Maryland, USA. The posters highlight the formulation and stabilization capabilities of recombinant albumin (rAlbumin) to safeguard the integrity of protein drug substances as well as the potential for combining hyaluronic acid (HA) and diclofenac sodium to extend drug release in osteoarthritis applications. For more information or to request a copy of the scientific posters, please visit booth #301 at the 2011 CRS meeting or www.biopharma.novozymes.com.

Greenphire Launches Unique ‘Site Payment Solution’ to Facilitate Sponsor Compliance with Physician Payment Sunshine Act

Philadelphia, PA, (7 July 2011). Greenphire, the industry leading provider of clinical payment and communication technology solutions, has announced the launch of its Clinical GPS technology, a unique site payment solution that streamlines and automates the clinical payment process for sponsors of all sizes. The system provides the ultimate solution for compliance with the recently passed federal Physician Payment Sunshine Act, enabling clients to make the required disclosures and reports effortlessly.

SmartKem’s Novel Organic Semiconductor Materials Achieve ‘Better Than Amorphous-Silicon’ Performance

(5 July, 2011) – SmartKem Limited, the developer of novel, printable organic semiconductor materials and ink formulations for flexible electronics announced that its advanced semiconductor materials have achieved performance “better than amorphous-silicon” in recent testing, achieving an impressive TFT mobility rating, higher than other traditional organic equivalents.

The testing was carried out by the UK’s National Printable Electronics Technology Centre (PETEC) by incorporating SmartKem’s semiconductors into flexible thin film transistor (TFT) panels and assessed performance using a range of industry standard test methods. The device preparation was performed in ambient air indicating the excellent stability of this material ink formulation.

Wyatt Technology’s Möbius Mobility Instrument Facilitates Protein Net Charge Computation at Low Concentrations

(SANTA BARBARA, CALIFORNIA – July 5 2011) - Wyatt Technology Corporation, the world leader in instrumentation for absolute macromolecular characterization and software, announces that its Möbius electrophoretic mobility instrument can measure precise protein charges. The innovative optical design of the Möbius boosts the sensitivity of mobility measurements, enabling protein net charge characterization at much lower concentrations than previously possible. This unique capability is illustrated in a new application note, titled “Möbius Computation of Protein Net Charge from Electrophoretic Mobility”, which is available to download free-of-charge via http://www.wyatt.com/literature/application-notes/mobius.html.

Protein molecules carry charges that are influenced by their environment, amino acid sequence, ionic strength and the aqueous solvent pH in which they are dissolved. The net charge carried by protein molecules is of enormous scientific interest since it affects the behavior of the molecules. As the ionic strength of the solution increases, for example, more counter ions are present in the vicinity of the protein molecules and the mobility generally decreases due to the electrophoretic effect. However, measuring protein charge has been a challenging task for conventional phase analysis light scattering (PALS) instruments that can only provide measurements at high concentrations and at high voltages. In addition, undesirable interactions can often occur, such as that between the proteins and the capillary walls, which diminish the reliability of results.

Thermo Fisher Scientific Recognized as Winner of the 2011 Microsoft Life Sciences Innovation Awards for Fourth Year in a Row

Thermo Scientific LIMS transforms information management solution at Nova Biologicals

PHILADELPHIA (June 30, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is a 2011 winner of Microsoft Corporation’s Life Sciences Innovation Awards. This is the fourth consecutive year that the company has been recognized by Microsoft, demonstrating Thermo Fisher’s leading position as a provider of innovative enterprise informatics solutions to the life sciences industry.

The awards, announced at the Drug Information Association’s (DIA) 47th annual meeting in Chicago, honor companies using Microsoft solutions to realize business and information technology benefits. This year’s notable winners are revolutionizing medicine by bringing therapeutic breakthroughs to the market faster to fight serious ailments, improve healthcare and enhance people’s quality of life.